Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Guided Therapeutics Inc (GTHP)

Guided Therapeutics Inc (GTHP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 30,342
  • Shares Outstanding, K 86,692
  • Annual Sales, $ 10 K
  • Annual Income, $ -2,420 K
  • EBIT $ -2 M
  • EBITDA $ -2 M
  • 60-Month Beta 0.57
  • Price/Sales 168.57
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings $-0.01 on 11/13/25
  • Next Earnings Date 03/30/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2506 +39.66%
on 02/25/26
0.4999 -29.99%
on 02/18/26
-0.0795 (-18.51%)
since 02/02/26
3-Month
0.1840 +90.22%
on 12/10/25
0.5400 -35.19%
on 01/05/26
+0.1000 (+40.00%)
since 12/01/25
52-Week
0.0644 +443.48%
on 04/10/25
0.5400 -35.19%
on 01/05/26
+0.2379 (+212.22%)
since 02/25/25

Most Recent Stories

More News
Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology,...

GTHP : 0.3500 (-5.41%)
Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor

Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $88,000 from distribution partner Hangzhou Dongye Medical Technology...

GTHP : 0.3500 (-5.41%)
Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had completed an initial supply agreement with Yuanshuo Medical Instruments Corporation (YMIC). YMIC...

GTHP : 0.3500 (-5.41%)
Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings

Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that on August 14 th 2025, it had received a payment of $70,000 from its new distribution...

GTHP : 0.3500 (-5.41%)
Guided Therapeutics Provides Update on Completion of US FDA Clinical Trial

Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology,...

GTHP : 0.3500 (-5.41%)
Guided Therapeutics Provides Update on Start of Clinical Trial for US FDA Approval

Guided Therapeutics, Inc. or the “Company” (OTCQB: GTHP), the maker of LuViva, a rapid and painless cervical cancer detection system based on the Company’s patented biophotonic technology, provided...

GTHP : 0.3500 (-5.41%)
Guided Therapeutics Announces New Agreement and Purchase Orders from Shandong Yaohua Medical Instrument Corporation

Guided Therapeutics, Inc. (the “ Company ”) (OTCQB: GTHP), the maker of the LuViva® Advanced Cervical Scan, announced today that it had signed a new agreement (the “ Agreement ”) with the Company’s...

GTHP : 0.3500 (-5.41%)
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval

Guided Therapeutics, Inc. or the “Company” (OTCQB: GTHP), the maker of LuViva, a rapid and painless cervical cancer detection system based on the Company’s patented biophotonic technology, announced...

GTHP : 0.3500 (-5.41%)
Guided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical Scan

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, based on its patented biophotonic technology, announced today that the clinical trial for Chinese regulatory is...

GTHP : 0.3500 (-5.41%)
Guided Therapeutics Closes $3.3 Million Bridge Financing

Guided Therapeutics, Inc. or the “Company” (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it had raised approximately...

GTHP : 0.3500 (-5.41%)

Business Summary

GUIDED THERAPEUTICS, Inc. is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. Unlike Pap and HPV tests, the...

See More

Key Turning Points

3rd Resistance Point 0.3696
2nd Resistance Point 0.3598
1st Resistance Point 0.3549
Last Price 0.3500
1st Support Level 0.3402
2nd Support Level 0.3304
3rd Support Level 0.3255

See More

52-Week High 0.5400
Fibonacci 61.8% 0.3583
Last Price 0.3500
Fibonacci 50% 0.3022
Fibonacci 38.2% 0.2461
52-Week Low 0.0644

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar